Absci

Absci Interest Expense

The Interest Expense of Absci (ABSI) as of Oct 17, 2026 is -565,000.00 USD. In the previous year, Interest Expense was -1.01 M USD — a change of -44.06% (higher).

Interest Expense

-565,000.00USD

YoY

-44.06%

Last updated:

Interest Expense of Absci is 2024 -565,000.00 USD. Interest Expense of Absci was 2023 -1.01 M USD. It decreases by -44.06% higher compared to the previous year.

The Absci Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2019
-270,000.00 USD
Jan 1, 2020
-630,000.00 USD
Jan 1, 2021
-3.43 M USD
Jan 1, 2022
-970,000.00 USD
Jan 1, 2023
-1.01 M USD
Jan 1, 2024
-565,000.00 USD
The Absci Interest Expense history
YEARInterest ExpenseYoY
-565,000.00USD-44.06%
-1.01 MUSD+4.12%
-970,000.00USD-71.72%
-3.43 MUSD+444.44%
-630,000.00USD+133.33%
-270,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Absci Stock analysis

What does Absci do? Absci Corp, trading under the ticker ABSI with ISIN US00091E1091, is a biotechnology company headquartered in Vancouver, Washington, operating within the Health Care sector. The company went public via an IPO on July 22, 2021. Absci employs 140 people. It leverages artificial intelligence and synthetic biology to explore and expand the therapeutic potential of proteins. The company utilizes a platform combining AI with scalable wet lab technologies to develop biologics for patients. Absci's approach involves identifying novel drug targets, discovering biotherapeutic candidates, and generating cell lines for manufacturing within a single integrated process. The firm applies generative AI to design drug candidates optimized for target affinity, safety, manufacturability, and other characteristics. Absci's technology includes SoluPro, a multiplex synthetic biology method that addresses limitations of high-throughput automation labs. The company supports its AI-driven designs with high-throughput functional validation capabilities in its wet lab. Absci's website is www.absci.com, providing information about its services and technology. The company focuses on creating biologic drug candidates for partners, using data generated from its processes to refine and improve its platform. Absci is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Absci stock

Interest Expense of Absci is -565,000.00 USD in 2024.

Interest Expense of Absci changed from -1.01 M USD to -565,000.00 USD, representing a -44.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Absci since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Absci historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Absci

All Key Metrics — Absci